Cargando…
Metabotropic Glutamate Receptor 7: A New Therapeutic Target in Neurodevelopmental Disorders
Neurodevelopmental disorders (NDDs) are characterized by a wide range of symptoms including delayed speech, intellectual disability, motor dysfunction, social deficits, breathing problems, structural abnormalities, and epilepsy. Unfortunately, current treatment strategies are limited and innovative...
Autores principales: | Fisher, Nicole M., Seto, Mabel, Lindsley, Craig W., Niswender, Colleen M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6206046/ https://www.ncbi.nlm.nih.gov/pubmed/30405350 http://dx.doi.org/10.3389/fnmol.2018.00387 |
Ejemplares similares
-
Corrigendum: Metabotropic Glutamate Receptor 7: A New Therapeutic Target in Neurodevelopmental Disorders
por: Fisher, Nicole M., et al.
Publicado: (2018) -
T39. NEURAL MECHANISMS OF METABOTROPIC GLUTAMATE RECEPTOR 3 MEDIATED ENHANCEMENT OF SYNAPTIC PLASTICITY AND COGNITION
por: Stansley, Branden, et al.
Publicado: (2018) -
Role of Metabotropic Glutamate Receptors in Neurological Disorders
por: Crupi, Rosalia, et al.
Publicado: (2019) -
Group II Metabotropic Glutamate Receptors: Role in Pain Mechanisms and Pain Modulation
por: Mazzitelli, Mariacristina, et al.
Publicado: (2018) -
Editorial: Metabotropic Glutamate Receptors and Neurological/Psychiatric Disorders
por: Palazzo, Enza, et al.
Publicado: (2019)